Additionally, expanding indications aims to tap into new markets
Then the larger TriNetX analysis presented at ACR 2025 more than 12,000 semaglutide users, propensity-matched showed lower risk of stiffness, swelling, pain, and synovitis at 30 days, 3 months, and a year
Lifestyle Changes You may be able to control body odor by making changes to your diet
Additionally, in the OASIS 1 trial (19), oral semaglutide at a dose of 50 mg, which is not yet available for clinical use in obesity or type 2 diabetes, induced an average of 15% weight loss, with 85% of participants achieving at least 5% weight loss (compared to 26% with placebo) and 54% achieving at least 15% weight loss
Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society